Skip to main content
. Author manuscript; available in PMC: 2013 May 10.
Published in final edited form as: Sci Signal. 2009 Sep 22;2(89):ra57. doi: 10.1126/scisignal.2000205

Fig. 7.

Fig. 7

Model for MSK2 regulation of p53 activity at the Noxa promoter. In the absence of stimuli, MSK2 suppresses Noxa transcription by interfering with p300 cotranscriptional activity and p300-mediated p53 acetylation. Apoptotic stimuli, such as UVC and cisplatin, trigger MSK2 degradation alleviating the repression of p300 and allowing p53-mediated transcriptional activation of the Noxa promoter.